Exploring neurocircuitries of the basal ganglia by intracerebral administration of selective neurotoxins
- Cite this article as:
- Herrera-Marschitz, M., Bustamante, D., Morales, P. et al. neurotox res (2007) 11: 169. doi:10.1007/BF03033566
- 56 Downloads
The detailed anatomy of the monoamine pathways of the rat, first described by the students of Nils-Åke Hillarp in Sweden, provided the basis for a neurocircuitry targeted pharmacology, leading to important therapeutic breakthroughs. Progress was achieved by the introduction of accurate lesion techniques based on selective neurotoxins. Systematic intracerebral injections of 6-hydroxydopamine let Urban Ungerstedt at the Karolinska Institutet, Stockholm, Sweden, to propose the first stereotaxic mapping of the monoamine pathways in the rat brain; and the ‘Rotational Behaviour’, as a classical model for screening drugs useful for alleviating Parkinson’s disease and other neuropathologies. The direction of the rotational behaviour induced by drugs systematically administrated to unilaterally 6-hydroxydopamine-lesioned rats reveals their mechanism of action at dopamine synapses, as demonstrated when rotational behaviour was combined with microdialysis. The model was useful for proposing a role of dopamine receptors in the gating of the flow of information integrated and/or modulated by the basal ganglia, through different efferent pathways; notably the striatopallidal system, via D2 receptors, and the striatonigral system, via D1 receptors. The role of other dopamine receptor subtypes on rotational behaviour has not yet been clarified.